Actively Recruiting
Rheumatologic Biobank for Clinical and Basic Research: Isolation, Extraction and Storage of Protein, DNA and RNA from Patient Tissues with Rheumatoid Diseases
Led by Meir Medical Center · Updated on 2019-03-11
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting blood, synovial fluid, and skin biopsy samples from adult patients with rheumatoid diseases to create a biobank for clinical and basic research. The study focuses on autoimmune rheumatic diseases, which are chronic inflammatory conditions influenced by genetic and environmental factors. By analyzing proteins, DNA, and RNA from these samples, researchers aim to better understand disease development, progression, and response to therapy, contributing to personalized medicine. Samples are collected from patients who consent and may be taken at diagnosis or follow-up visits. Blood samples are drawn by certified staff, synovial fluid and skin biopsies by physicians, under routine clinical care without treatment delays. Samples are processed, stored securely in the biobank, and coded to protect patient privacy. Researchers from various institutions can request samples for approved studies following strict ethical guidelines. Participants provide informed consent and may withdraw anytime, stopping use of their samples. Researchers will measure proteins and genetic material from the samples to support various studies. The biobank aims to collect about 500 samples yearly, with storage planned for 20 years. Privacy protections, sample handling protocols, and long-term storage plans ensure participant rights and sample integrity throughout the study.
CONDITIONS
Brief Title
Meir Medical Center Rheumatologic Biobank
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Above 18 years of age
- Willing to sign informed consent
- Diagnosed with a rheumatoid condition such as rheumatoid arthritis, lupus, systemic sclerosis, IgG4-related disease, or Sjogren's syndrome
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 20 years
Participants provide blood, synovial fluid, or skin tissue samples for isolation, extraction, and storage of protein, DNA, and RNA related to their rheumatic disease. Samples are collected at diagnosis, during routine clinical visits, or at major clinical events such as flare, relapse, or remission.
Samples are collected during routine clinical visits as ordered by the treating physician, with timing depending on clinical events and follow-up schedules.
Trial Site Locations
Total: 1 location
1
Meir Medical Center
Kfar Saba, Israel
Actively Recruiting
Research Team
Y
Yair Levy, Prof.
N
Noa Rabinowicz, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here